K. A. Fiedler

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

H. Schunkert, A. Kastrati, J. Mehilli, 2015, Journal of the American College of Cardiology.

Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, J. Mehilli, 2022 .

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Thrombosis and Haemostasis.

Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention

A. Kastrati, F. Neumann, G. Ndrepepa, 2013, Circulation. Cardiovascular interventions.

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Procedure‐related bleeding in elective percutaneous coronary interventions

A. Kastrati, G. Ndrepepa, S. Kufner, 2015, European journal of clinical investigation.

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation.

H. Schunkert, A. Kastrati, J. Mehilli, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.